CleanSleep Product Development Update – SLEEP 2026
CleanSleep Progress Update
Following our participation at SLEEP 2026, we are excited to share the latest progress on CleanSleep, an innovative automated CPAP cleaning solution designed to simplify equipment maintenance and support long-term therapy compliance.
Working Prototype Successfully Demonstrated
CleanSleep has reached an important milestone with the development of a working prototype. During SLEEP 2026, attendees had the opportunity to learn about the technology, view demonstrations, and provide valuable feedback that will help guide the next phase of development.
A Special Investment Opportunity
Dear Colleague,
Thanks for visiting us at SLEEP 2026!
As you know our company exhibited at the SLEEP 2026 Conference in Baltimore, one of the largest gatherings of sleep medicine professionals in the world. The conference attracted approximately 6,000 attendees, including physicians, researchers, sleep specialists, and more than 150 exhibiting companies.
Late on the second day, a practicing physician approached our booth with one of his associates in tow. As he arrived, he pointed to our product and said, “Your product is, without question, the best product at this conference.”
He was not a customer. He was not an investor. He had no reason to say it other than that he genuinely believed it.
That moment reinforced something our team has believed for some time: we have developed a product that addresses a real need in a large and growing market.
Our company manufactures an innovative CPAP cleaning solution designed to help the millions of people who rely on CPAP therapy maintain their equipment more effectively and conveniently. We believe the opportunity before us is significant, and we are now raising additional capital to accelerate growth and expand our market presence.
Share Offering
We are offering shares of the company at:
- $1.00 per share
- Minimum investment: $10,000
- Minimum purchase: 10,000 shares
Early Investor Incentive
As a special incentive for friends and associates who act promptly, any investment received within the next 30 days will qualify for a discounted purchase price of $0.80 per share.
At the discounted price, a $10,000 investment would purchase 12,500 shares, representing a 25% increase in the number of shares received.
Why We Are Raising Capital
The funds raised will be used to:
- Expand sales and marketing efforts
- Increase production and inventory capacity
- Support product development initiatives
- Strengthen our overall growth strategy
I (Dr. Kakar) have personally invested substantial time, energy, and resources into this company because I believe in both the product and the opportunity. While every investment involves risk and there can be no guarantees of success, we are excited about where we are headed and wanted to offer friends and associates the opportunity to participate alongside us.
If you would like additional information about the company, our products, management team, or the investment opportunity, please contact us directly. We would be happy to discuss the business and answer any questions you may have.
If you are ready to make an investment, just reply to this email and we will send you the subscription agreement and related documents.
Thank you for taking the time to consider this opportunity. We look forward to speaking with you. Also, please feel free to reach out to our CFO Michael Manahan at 213-675-6157 for any investment-related questions.
